These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 23311295)

  • 1. BEACOPP escalated and rituximab in the treatment of Hodgkin lymphoma occurring concurrently with diffuse large B-cell non-Hodgkin lymphoma.
    Palickova M; Mocikova H; Vernerova Z; Campr V; Kozak T
    Leuk Lymphoma; 2013 Sep; 54(9):2081-2. PubMed ID: 23311295
    [No Abstract]   [Full Text] [Related]  

  • 2. PET2 -driven de-escalation therapy in 64 high-risk Hodgkin Lymphoma patients treated with escalated BEACOPP.
    Deau B; Franchi P; Briere J; Ohnona J; Tamburini J; Thieblemont C; Brice P
    Br J Haematol; 2015 Jul; 170(2):278-81. PubMed ID: 25580881
    [No Abstract]   [Full Text] [Related]  

  • 3. Ten years' experience with four cycles of bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, prednisone, procarbazine (BEACOPP)-escalated followed by four cycles of baseline-dose BEACOPP in patients with advanced stage Hodgkin lymphoma: a single-center, retrospective study.
    Belada D; Štěpánková P; Sýkorová A; Žák P; Smolej L
    Leuk Lymphoma; 2015 Jul; 56(7):2013-8. PubMed ID: 25330440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Occurrence of sarcoidosis after chemotherapy for non-Hodgkin lymphoma.
    Cho H; Yoon DH; Kim JH; Ko YB; Kwon BS; Song IH; Suh C
    Korean J Intern Med; 2016 May; 31(3):605-7. PubMed ID: 26968186
    [No Abstract]   [Full Text] [Related]  

  • 5. Autotransplant for Hodgkin lymphoma after failure of upfront BEACOPP escalated (bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine and prednisone).
    Wannesson L; Bargetzi M; Cairoli A; Cerutti A; Heim D; Hess U; Lerch E; Pabst T; Renner C; Samaras P; Zucca E
    Leuk Lymphoma; 2013 Jan; 54(1):36-40. PubMed ID: 22702653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sarcoidosis following escalated BEACOPP chemotherapy for stage IV Hodgkin lymphoma.
    Cho KK; Lyes SM; Shetty A
    Intern Med J; 2019 Apr; 49(4):547-548. PubMed ID: 30957369
    [No Abstract]   [Full Text] [Related]  

  • 7. Modified escalated BEACOPP as salvage chemotherapy in classic Hodgkin lymphoma.
    Fesler MJ; Nguyen NC; Petruska PJ
    Int J Hematol; 2010 Jul; 92(1):211-3. PubMed ID: 20582576
    [No Abstract]   [Full Text] [Related]  

  • 8. Escalated BEACOPP in advanced Hodgkin's lymphoma.
    Casasnovas O; Coiffier B
    Lancet; 2012 May; 379(9828):1767-8. PubMed ID: 22480757
    [No Abstract]   [Full Text] [Related]  

  • 9. [Management of lymphoma with respect to pathologic classification: updates and controversies].
    Zhu J; Song YQ
    Zhonghua Bing Li Xue Za Zhi; 2009 Nov; 38(11):724-7. PubMed ID: 20079009
    [No Abstract]   [Full Text] [Related]  

  • 10. [Rituximab combined with second line regimens for treatment of seven relapsed and refractory Hodgkin lymphoma patients].
    Liu H; Li H; Xiong W; Yi S; Zou D; Qiu L
    Zhonghua Xue Ye Xue Za Zhi; 2015 Jul; 36(7):578-82. PubMed ID: 26304082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted BEACOPP Variants in Patients With Newly Diagnosed Advanced Stage Classical Hodgkin Lymphoma: Final Analysis of a Randomized Phase II Study.
    Clin Adv Hematol Oncol; 2016 Feb; 14(2 Suppl 1):9-10. PubMed ID: 27007004
    [No Abstract]   [Full Text] [Related]  

  • 12. Current clinical trials for the treatment of advanced-stage Hodgkin's disease: BEACOPP.
    Franklin J; Diehl V
    Ann Oncol; 2002; 13 Suppl 1():98-101. PubMed ID: 12078913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Homonymous hemianopsia in a patient with Hodgkin's lymphoma in remission after BEACOPP chemotherapy.
    Bruessow C; Karrer U; Gubler J; Pless M
    J Clin Oncol; 2012 Apr; 30(12):e130-2. PubMed ID: 22393099
    [No Abstract]   [Full Text] [Related]  

  • 14. Eight cycles of escalated-dose BEACOPP compared with four cycles of escalated-dose BEACOPP followed by four cycles of baseline-dose BEACOPP with or without radiotherapy in patients with advanced-stage hodgkin's lymphoma: final analysis of the HD12 trial of the German Hodgkin Study Group.
    Borchmann P; Haverkamp H; Diehl V; Cerny T; Markova J; Ho AD; Eich HT; Mueller-Hermelink HK; Kanz L; Greil R; Rank A; Paulus U; Smardova L; Huber C; Dörken B; Nerl C; Krause SW; Mueller RP; Fuchs M; Engert A
    J Clin Oncol; 2011 Nov; 29(32):4234-42. PubMed ID: 21990399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early intensification treatment approach in advanced-stage Hodgkin lymphoma.
    Borchmann P
    Hematol Oncol Clin North Am; 2014 Feb; 28(1):65-74. PubMed ID: 24287068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prophylactic use of filgrastim with ABVD and BEACOPP chemotherapy regimens for Hodgkin lymphoma.
    Wedgwood A; Younes A
    Clin Lymphoma Myeloma; 2007 Dec; 8 Suppl 2():S63-6. PubMed ID: 18284718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ABVD, the Stanford V regimen, and BEACOPP for Hodgkin's lymphoma: what should an oncologist do?
    Connors JM
    Clin Lymphoma; 2005 Jun; 6(1):50-1. PubMed ID: 15989708
    [No Abstract]   [Full Text] [Related]  

  • 18. Secondary amenorrhea after Hodgkin's lymphoma is influenced by age at treatment, stage of disease, chemotherapy regimen, and the use of oral contraceptives during therapy: a report from the German Hodgkin's Lymphoma Study Group.
    Behringer K; Breuer K; Reineke T; May M; Nogova L; Klimm B; Schmitz T; Wildt L; Diehl V; Engert A;
    J Clin Oncol; 2005 Oct; 23(30):7555-64. PubMed ID: 16234521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PET-2-guided escalated BEACOPP for advanced nodular lymphocyte-predominant Hodgkin lymphoma: a subgroup analysis of the randomized German Hodgkin Study Group HD18 study.
    Eichenauer DA; Kreissl S; Bühnen I; Baues C; Kobe C; van Heek L; Goergen H; Fuchs M; Hartmann S; von Tresckow B; Engert A; Borchmann P
    Ann Oncol; 2021 Jun; 32(6):807-810. PubMed ID: 33667668
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of the efficiency of ABVD versus BEACOPP for Hodgkin lymphoma treatment: a meta-analysis.
    Jiang Y; Chen Y; Huang R; Chen G
    Int J Hematol; 2016 Oct; 104(4):413-9. PubMed ID: 27531149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.